Quantitative fluorescence molecular imaging in highly light-absorbing melanomas using a dual-tracer kinetic modeling normalization method
暂无分享,去创建一个
Tayyaba Hasan | Kenneth M. Tichauer | Stephen C. Kanick | Brian W. Pogue | Kimberley S. Samkoe | Sophie J. Deharvengt | Radu V. Stan | Sophie J Deharvengt | B. Pogue | T. Hasan | K. Tichauer | R. Stan | S. Kanick | K. Samkoe
[1] R K Jain,et al. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. , 1990, Cancer research.
[2] Walter H Backes,et al. Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice. , 2005, Radiology.
[3] Jason R. Gunn,et al. In Vivo Quantification of Tumor Receptor Binding Potential with Dual-Reporter Molecular Imaging , 2012, Molecular Imaging and Biology.
[4] S. Kety. The theory and applications of the exchange of inert gas at the lungs and tissues. , 1951, Pharmacological reviews.
[5] Jason R. Gunn,et al. Tumor Endothelial Marker Imaging in Melanomas Using Dual-Tracer Fluorescence Molecular Imaging , 2014, Molecular Imaging and Biology.
[6] R. Stan. Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis , 2007, Journal of cellular and molecular medicine.
[7] Viatcheslav R Akmaev,et al. Vascular gene expression in nonneoplastic and malignant brain. , 2004, The American journal of pathology.
[8] Brian W. Pogue,et al. Fluorescent Affibody Peptide Penetration in Glioma Margin Is Superior to Full Antibody , 2013, PloS one.
[9] J. Frangioni,et al. Image-Guided Surgery Using Invisible Near-Infrared Light: Fundamentals of Clinical Translation , 2010, Molecular imaging.
[10] Christopher H Contag,et al. Quantifying cell-surface biomarker expression in thick tissues with ratiometric three-dimensional microscopy. , 2009, Biophysical journal.
[11] R. DePinho,et al. BRafV600E cooperates with Pten silencing to elicit metastatic melanoma , 2009, Nature Genetics.
[12] A. Jubb,et al. Plasmalemmal vesicle‐associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor‐A (VEGF) , 2005, The Journal of pathology.
[13] Rakesh K. Jain,et al. Vascular and interstitial barriers to delivery of therapeutic agents in tumors , 1990, Cancer and Metastasis Reviews.
[14] Tayyaba Hasan,et al. Imaging targeted-agent binding in vivo with two probes. , 2010, Journal of biomedical optics.
[15] I. Meglinski,et al. Quantitative assessment of skin layers absorption and skin reflectance spectra simulation in the visible and near-infrared spectral regions. , 2002, Physiological measurement.
[16] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[17] R. P. Maguire,et al. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.